Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bey

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Neurosurgery. Spine|October 16, 2014
Hypermobility accelerates adjacent-segment disease after ACDF? ResponseVictor Chang, Stephen Bartol, Michael Bey
The American Journal of Sports Medicine|September 18, 2014
Altered tibiofemoral kinematics in the affected knee and compensatory changes in the contralateral knee after anterior cruciate ligament reconstructionMarcus Hofbauer, Eric D Thorhauer, Ermias Abebe, et al.
Stapp Car Crash Journal|February 19, 2008
A study of the response of the human cadaver head to impactWarren N Hardy, Matthew J Mason, Craig D Foster, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Mitigating hERG Inhibition: Design of Orally Bioavailable CCR5 Antagonists as Potent Inhibitors of R5 HIV-1 ReplicationRenato Skerlj, Gary Bridger, Yuanxi Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|October 29, 2011
Design and synthesis of pyridin-2-ylmethylaminopiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replicationRenato Skerlj, Gary Bridger, Yuanxi Zhou, et al.
Journal of Medicinal Chemistry|October 5, 2013
Design of substituted imidazolidinylpiperidinylbenzoic acids as chemokine receptor 5 antagonists: potent inhibitors of R5 HIV-1 replicationRenato Skerlj, Gary Bridger, Yuanxi Zhou, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Neurosurgery. Spine|October 16, 2014
Hypermobility accelerates adjacent-segment disease after ACDF? ResponseVictor Chang, Stephen Bartol, Michael Bey
The American Journal of Sports Medicine|September 18, 2014
Altered tibiofemoral kinematics in the affected knee and compensatory changes in the contralateral knee after anterior cruciate ligament reconstructionMarcus Hofbauer, Eric D Thorhauer, Ermias Abebe, et al.
Stapp Car Crash Journal|February 19, 2008
A study of the response of the human cadaver head to impactWarren N Hardy, Matthew J Mason, Craig D Foster, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Mitigating hERG Inhibition: Design of Orally Bioavailable CCR5 Antagonists as Potent Inhibitors of R5 HIV-1 ReplicationRenato Skerlj, Gary Bridger, Yuanxi Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|October 29, 2011
Design and synthesis of pyridin-2-ylmethylaminopiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replicationRenato Skerlj, Gary Bridger, Yuanxi Zhou, et al.
Journal of Medicinal Chemistry|October 5, 2013
Design of substituted imidazolidinylpiperidinylbenzoic acids as chemokine receptor 5 antagonists: potent inhibitors of R5 HIV-1 replicationRenato Skerlj, Gary Bridger, Yuanxi Zhou, et al.
Pageof 1